Help for Parkinson's Fall Gala Friday, October 23, 2026 6:00–9:30 PM Colonie Golf & Country Club 13 Country Club Lane, Voorheesville, NY 12186 Help for Parkinson’s invites you to join us for our annual fall gala, an evening of fine dining, live music, and community! Keynote speaker is Steven Yellen author of Living Parkinson’s Dinner ~ Dancing & Music by TS Ensemble Tickets $150 per person 100% of the funds raised at this event support Parkinson’s programming and research thr

The once-daily oral medication, developed by AbbVie, targets dopamine receptors differently from existing therapies and offers a new treatment option for adults living with Parkinson’s disease. The U.S. Food and Drug Administration (FDA) has approved tavapadon, marketed under the brand name Juvmo, as a new treatment for adults with Parkinson’s disease. Developed by AbbVie, the once-daily oral medication is designed to help manage motor symptoms and can be taken with or withou

Could the way you walk reveal one of the early signs of Parkinson’s disease years before a diagnosis? New research suggests that subtle changes in everyday walking may be associated with Parkinson’s disease long before traditional symptoms become obvious. Using data from wearable motion sensors, researchers identified several differences in walking patterns among people who were later diagnosed with Parkinson’s. The findings add to growing research into early Parkinson’s dete

For decades, researchers have investigated whether certain environmental exposures may contribute to the development of Parkinson’s disease. One chemical that has received particular attention is paraquat, a commercial herbicide used in agriculture. Now, a bipartisan group of lawmakers has introduced legislation that would seek to remove paraquat from the U.S. market. On June 18, 2026, Representatives Anna Paulina Luna, a Florida Republican, and Chellie Pingree, a Maine Democ

Parkinson’s disease is commonly associated with older age, but the condition can also affect people much earlier in life. An estimated 5% to 10% of people diagnosed with Parkinson’s develop the disease before reaching age 50. This form is often referred to as early-onset Parkinson’s disease (EOPD). A Parkinson’s diagnosis during the 20s, 30s, or 40s can bring challenges that are very different from those faced later in life. Younger adults may be building careers, supporting